id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-D-0038-0150,FDA,FDA-1998-D-0038,"Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on
Bacteria of Human Health Concern; Revised Draft Guidance for Industry; Availability; Extension of  Comment Period",Notice,Extension of Comment Period,2023-03-07T05:00:00Z,2023,3,2023-03-07T05:00:00Z,,2023-03-07T14:15:54Z,2023-04562,0,0,090000648576d523
FDA-1998-D-0038-0011,FDA,FDA-1998-D-0038,"Request for Extension from American Association of Swine Veterinarians, National Pork Producers Council, North American Meat Institute",Other,Request for Extension,2023-02-01T05:00:00Z,2023,2,2023-02-01T05:00:00Z,,2023-02-01T17:34:56Z,,0,0,0900006485621c39
FDA-1998-D-0038-0010,FDA,FDA-1998-D-0038,Request for Extension from American Veterinary Medical Association (AVMA),Other,Request for Extension,2023-01-20T05:00:00Z,2023,1,2023-01-20T05:00:00Z,,2023-01-20T17:43:49Z,,0,0,09000064855fa270
FDA-1998-D-0038-0008,FDA,FDA-1998-D-0038,Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern; Revised Draft Guidance for Industry; Availability,Other,Guidance,2022-12-19T05:00:00Z,2022,12,2022-12-19T05:00:00Z,2023-05-20T03:59:59Z,2024-11-12T23:49:56Z,,1,0,09000064855401e6
FDA-1998-D-0038-0007,FDA,FDA-1998-D-0038,Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern; Revised Draft Guidance for Industry; Availability,Notice,Notice of Availability,2022-12-19T05:00:00Z,2022,12,2022-12-19T05:00:00Z,,2022-12-19T13:50:31Z,2022-27415,0,0,0900006485540064
FDA-1998-D-0038-0005,FDA,FDA-1998-D-0038,Tina Wimbush,Other,LET-Letter,2003-11-14T05:00:00Z,2003,11,,,2008-05-16T21:22:42Z,,0,0,090000648056e1ed
FDA-1998-D-0038-0006,FDA,FDA-1998-D-0038,Tina Wimbush,Other,LET-Letter,2003-11-14T05:00:00Z,2003,11,,,2008-05-16T21:18:50Z,,0,0,090000648056e1ee
FDA-1998-D-0038-0004,FDA,FDA-1998-D-0038,FDA,Notice,NAD-Notice of Availability of Data,2003-10-28T05:00:00Z,2003,10,2003-10-27T05:00:00Z,,2008-05-16T21:22:42Z,,0,0,090000648056e1e4
FDA-1998-D-0038-0003,FDA,FDA-1998-D-0038,Guidance,Supporting & Related Material,GDL-Guidance,2003-10-28T05:00:00Z,2003,10,,,2008-05-16T21:22:08Z,,0,0,090000648056e1e3
FDA-1998-D-0038-0002,FDA,FDA-1998-D-0038,FDA,Notice,N-Notice,2003-09-29T04:00:00Z,2003,9,2003-09-19T04:00:00Z,,2008-05-16T21:21:03Z,,0,0,090000648056e1dc
FDA-1998-D-0038-0001,FDA,FDA-1998-D-0038,HFV-012,Notice,NAD-Notice of Availability of Data,1999-01-19T05:00:00Z,1999,1,1999-01-19T05:00:00Z,1999-04-07T03:59:59Z,2008-05-16T21:22:16Z,,0,0,0900006480565cf7